Please Explain: Covid Vax but still Coviddy? Blood Clots? What! By Mrs Vera West

It is enough to make one giddy; the Covid jabs were supposed to be 100 percent effective, yet, over the cesspool, down Beijing Biden way, we have this “please explain,” a phrase that Pauline apparently does not use anymore, so I will steal it.

“Michigan, now the epicenter of the American COVID outbreak, is desperately begging the federal government for more vaccines. But reports about a rash of infections in "fully vaccinated" patients might provoke a rethink.

The Detroit News reported that as many as 246 vaccinated Michigan residents later tested positive for the deadly bug, including three who have died. The cases were reported between Jan. 1 and March 31, and the 246 had a positive test 14 or more days after the last dose in the vaccine series, said Lynn Sutfin, a spokeswoman for the Michigan Department of Health and Human Services.

"Some of these individuals may ultimately be excluded from this list due to continuing to test positive from a recent infection prior to being fully vaccinated," she said.

"These cases are undergoing further review to determine if they meet other CDC criteria for determination of potential breakthrough, including the absence of a positive antigen or PCR test less than 45 days prior to the post-vaccination positive test. In general, these persons have been more likely to be asymptomatic or mildly symptomatic compared with vaccinated persons."

The department had hospitalization data for 117 of the cases, but 129 were incomplete, Sutfin added. The three deaths were all "persons 65 years or older," and two of them died within three weeks of completion of vaccination, she said. "While the majority of the population develops full immunity within 14 days of completion of their vaccine series, a small proportion appear to take onger to mount a full antibody response." Of the 117 with data available, 11 were hospitalized, 103 were not hospitalized, and 3 are reported as unknown, Sutfin said.

As of April 4, about 2.95 million residents, or about 36.5% of Michigan's population, have been vaccinated, either with one or two doses, according to the state website. About 4.7M doses had been administered.

New cases have surged over the last month, pushing the 7-day average to its highest level since late last year. Even deaths have started to creep higher, a possible effect of mutant strains that are spreading faster in the state.”

And then there is the continuing saga of blood clots and AstraZeneca, which sounds like someone out of a video game, but apparently not, I must be thinking of Astrasomethingorother.

“The WHO has weighed in on today's comments from the EMA. Based on current information, a causal relationship between AstraZeneca’s Covid-19 vaccine and the occurrence of blood clots with low platelets is considered plausible, the organzation said, though it's not confirmed.

The COVID-19 subcommittee of the WHO Global Advisory Committee on Vaccine Safety reviewed reports of rare cases of blood clots with low platelets following vaccination since their onset a few weeks ago Subcommittee reviewed latest information from the European Medicines Agency and the UK's MHRA.

Weeks after its initial "safety review", where the EMA insisted that the risks posed by the AstraZeneca jab were outweighed by the massive societal benefit, dozens of new cases of blood clots have been detected, including 25 in the UK that have apparently been linked to the jab. The news prompted Oxford to cancel a trial of the vaccine involving young children. Yesterday, the EMA finally acknowledged that there might indeed be a link between the jab and the clots, but that it wasn't very clear.


Wednesday is "World Health Day", yet two regions in Spain have just announced new plans to suspend AstraZeneca shots to patients under 65, pending further clarification from the EMA.

"EMA is holding a virtual press briefing on the conclusion of the evaluation of a safety signal with Vaxzevria (formerly Covid-19 Vaccine AstraZeneca) relating to cases of thromboembolic events by EMA's safety committee," the agency said in a statement.

A few days ago, an Australian official acknowledged that a link between the jab and the brain blood clots could exist.”

In that case we had better ask the distinguished University of Oxford what they think:

“The University of Oxford announced on Tuesday, April 6, that it has suspended the trial on children and teenagers of the Wuhan coronavirus (COVID-19) vaccine that it developed jointly with AstraZeneca. The tests were halted as Oxford waits for further information from Britain’s top drug regulator about the vaccine’s possible link with rare blood clots in adults.

Oxford began its pediatric trial in mid-February when it enrolled 300 volunteers in Oxford, London and two other areas in the United Kingdom to participate in its vaccine trial. The volunteers consist of children between the ages of six to 17 who were signed up to participate by their parents. More than 200 of the children and teenagers will get the vaccine while the rest will get a placebo – a meningitis vaccine shot.

The university’s researchers said the children and teenagers who will receive the meningitis vaccine shot will serve as the trial’s control group. They claimed that the shot is safe for children, although it is expected to “produce similar reactions” to the coronavirus vaccine, such as soreness in the arm after injection.

A spokesman for the university said that no safety issues were noted before the trial was suspended. However, Oxford’s concerns regarding the deaths and the sudden onset of rare blood clots in adults have made the university wary of continuing the trial. It will only resume its vaccine tests on children once Britain’s top drug regulator – the Medicines and Healthcare Products Regulatory Agency (MHRA) – says it is acceptable to do so.

Oxford did not disclose how many participants have already received the AstraZeneca vaccine. It has contacted the parents of the participants to ask them to continue attending all of their scheduled visits with the trial sites. It is unclear whether these underage participants will continue receiving the coronavirus vaccine or if the university will merely monitor them to keep getting trial data.

“We are aware of the decision taken by the University of Oxford to pause dosing in the trial of the Oxford University and AstraZeneca COVID-19 vaccine trial in children whilst the MHRA safety review is ongoing,” said Dr. June Raine, head of the MHRA, in a statement. “Participant safety in any clinical trial is our top priority, and no safety concerns have been reported with this trial.”

The MHRA has stated that it is currently conducting a “thorough and detailed review” of the Oxford-AstraZeneca vaccine. At the same time, it has also denied any proven link between the life-threatening and rare blood clots and the vaccine.

According to MHRA, there have been 30 reported cases of blood clotting, seven of which were fatal. The agency tried to downplay the situation by claiming that the blood clotting condition is very rare since Oxford-AstraZeneca has administered over 18 million doses of its vaccine.

Meanwhile, the MHRA’s European counterpart, the European Medicines Agency (EMA), is likely to acknowledge the link between the clotting and the vaccine.

Dr. Marco Cavaleri, the EMA’s head of health threats and vaccine strategy, told an Italian newspaper that there is a clear association between the vaccine and the blood clotting incidents and deaths that have been reported based on the evidence that the EMA has. Unfortunately, Cavaleri does not believe the EMA’s conclusions on the matter will affect how European countries will proceed with their vaccine rollout plans.

“Of course, it would be preferable for there to be a single position at the European level,” said Cavaleri. “But … let’s not forget that COVID is hitting various countries differently. In Italy, 500 people are still dying every day [and] in Norway almost nobody is dying. These factors justify different approaches.”

Even the World Health Organization has commented on the situation. On Tuesday, it said that there was no reason to change its own assessment that the benefits of taking the AstraZeneca vaccine outweighed the risks.

While other European nations have suspended the AstraZeneca vaccine, or restricted its use only to certain portions of their populations, Britain has resisted any restrictions in its use, arguing that there has been no proof of any link between the vaccine and blood clots.”

It strikes me as very much like a kind of lottery, where the unlucky few get the no-prize of blood clots, and maybe die. Such is life, as Ned Kelly said before being hung.



No comments made yet. Be the first to submit a comment
Already Registered? Login Here
Monday, 19 April 2021
If you'd like to register, please fill in the username, password and name fields.

By accepting you will be accessing a service provided by a third-party external to